Market Research Logo

Prescription Dermatological Drugs: Worldwide Market, 6th Edition


Attention: There is an updated edition available for this report.

One of Kalorama's best-selling market research reports, this report provides the reader with a complete analysis of the domestic and international markets for pharmaceuticals to treat skin diseases and disorders. This edition of Worldwide Market for Prescription Dermatological Drugs is the sixth time Kalorama Information has comprehensively studied the dermatology markets.

Kalorama has completely re-evaluated the market from the ground up, and in addition to the usual primary research (interviews) of industry participants, clinicians, and regulators, we also conducted scores of interviews with users of Kalorama’s 2004 and 2006 dermatological studies to ensure that the current report contains the best possible data and the most useful analysis.

In this new edition, various shifts in the market are noted. There is information on bilogics, discussion of fillers and of treatments for skin infections such as MRSA. New companies have been added and consolidations in the industry have been addressed.

Market information is available for the years 2004 to 2011, with the focus year 2006 for competitive analysis. Overview and product descriptions of general therapy segments are covered, including prescription drugs to treat:

  • Acne and Rosacea
  • Antiaging and Photodamage
  • Dermatitis and Seborrhea
  • Fungal Infections
  • Hair Loss and Hair Removal
  • Hyperpigmentation/Melasma
  • Psoriasis
  • Skin Cancer, and
  • Other Skin Disorders

Other data points include competitive market share, demographics, epidemiology, and geographic break down, which provide revenues for four regions:

  • United States
  • Europe
  • Japan
  • Rest of world

The study covers issues and trends affecting the market, research and developments, and more. In particular, the study explores the current and potential effects of the aging baby boomers on the prescription dermatology market and the continued demand for lifestyle drugs. Profiles of major market participants are included, including:

  • Allergan Inc.
  • Allergan Inamed Corporation
  • Barrier Therapeutics, Inc
  • Bayer AG
  • Bradley Pharmaceuticals, Inc
  • Bristol-Myers Squibb
  • CollaGenex Pharmaceuticals
  • Galderma S.A.
  • Genentech, Inc.
  • GlaxoSmithKline Plc
  • Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
  • Medicis Pharmaceutical Corporation
  • Merck & Company, Inc.
  • Mylan Pharmaceuticals, Inc,
  • Novartis Pharmaceuticals Corporation
  • Nycomed Inc.
  • Pfizer, Inc.
  • Q-Med AB
  • Roche Group (F. Hoffmann-La Roche Ltd.)
  • Schering-Plough Corporation
  • Sinclair Pharma Plc.
  • SkinMedica
  • Stiefel Laboratories, Inc.
  • Valeant Pharmaceuticals, Inc.


Chapter One: Executive Summary

  • Scope and Methodology
  • Size and Growth of the Market
  • Issues and Trends Affecting Market
  • Competitor Analysis

Chapter Two: Introduction

  • Structure and Function of the Skin
  • Epidermis
  • Dermis
  • Subcutaneous Tissue
  • Epidermal Appendages
    • Functions of the Skin
    • Effects of Aging on the Skin
    • Dermatological Conditions and Treatment
    • Pharmacokinetics

  • Drug Absorption
  • Distribution
  • Bioavailability
    • Drug Delivery Methods
    • Demographics of Skin Disorders, Incidence, and Prevalence

Chapter Three: Issues and Trends

  • Cosmetic Dermatologists
  • Medicare Reimbursement
  • Melanoma Survival Rates Falter
  • New Filler Options
  • A Confusing Industry
  • Genetic Link to Psoriasis
  • Biologic Dermatology
  • Rx-to-OTC Switches
  • Cosmeceuticals
  • Antioxidants
  • Polypeptides
    • Teledermatology
    • Reimbursement Issues
    • Laser Therapy
    • Narrowband Ultraviolet B
    • Photodynamic Therapy
    • Importance of Drug Delivery

Chapter Four: Prescription Antiacne and Rosacea Drugs

  • Description of Disorders
  • Description of Products
  • Benzoyl Peroxide
    • Description of Products
    • Current Suppliers

  • Retinoids
    • Topical Formulations
      • All-trans Retinoic Acid (Tretinoin)
      • Adapalene
      • Tazarotene
    • Systemic Formulations
      • Isotretinoin
    • Current Suppliers

  • Antibiotics
    • Description of Products
      • Azelaic Acid
      • Clindamycin
      • Erythromycin
      • Metronidazole
      • Sodium Sulfacetamide
    • Current Suppliers

  • Oral Contraceptives
    • Research and Development
    • Market Size and Growth

  • Global Market
  • Markets by Geographical Region
    • United States
    • Europe
    • Europe
    • Japan
    • Rest of World

  • The Future of the Market
  • Competitive Analysis

Chapter Five: Prescription Antiaging and Photodamage Drugs

  • Overview
  • Description of Products
  • Keratolytics
  • Moisturizers
  • Retinoids
  • Sunscreens
  • Other Agents
    • Market Size and Growth

  • Global Market
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World

  • The Future of the Market
  • Competitive Analysis

Chapter Six: Prescription Dermatitis and Seborrhea Drugs

  • Overview
  • Description of Products
  • Topical Corticosteroids
  • Systemic Corticosteroids
  • Other Products
    • Research and Development
    • Market Size and Growth

  • Global Market by Type
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World

  • Future of the Market
  • Competitive Analysis

Chapter Seven: Prescription Antifungal Drugs

  • Overview
  • Description of Products
  • Systemic Formulations
    • Terbinafine
    • Itraconazole
    • Fluconazole
    • Griseofulvin
    • Ketoconazole
    • Current Suppliers

  • Topical Formulations
    • Polyenes
    • Azoles
      • Miconazole
      • Clotrimazole
      • Ketoconazole
      • Oxiconazole
      • Econazole
      • Sulconazole
    • Allylamines and Benzylamines
      • Naftifine
      • Terbinafine
      • Butenafine
    • Other Topical Formulations
    • Current Suppliers
    • Research and Development
    • Market Size and Growth

  • Global Market by Type
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World

  • Future of the Market
  • Competitive Analysis

Chapter Eight: Prescription Hair Loss and Hair Removal Drugs

  • Overview
  • Description of Products
  • Antiandrogens
  • Androgen Inhibitors
  • Oral Contraceptives
  • Other Treatments
    • Research and Development
    • Market Size and Growth

  • Global Market by Type
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World

  • Future of the Market
  • Competitive Analysis

Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs

  • Overview
  • Description of Products
  • Research and Development
  • Market Size and Growth
  • Global Market
  • Markets by Geographical Region
  • United States
  • Europe
  • Japan
  • Rest of World
    • The Future of the Market
    • Competitive Analysis

Chapter Ten: Prescription Psoriasis Drugs

  • Overview
  • Description of Products
  • Topical Psoriasis Products
    • Anthralin
    • Coal Tar
    • Methoxsalen
    • Second-generation Retinoids
    • Tazarotene
    • Topical Vitamin D
    • Vitamin D Analogs
    • Vanos

  • Systemic Psoriasis Preparations
    • Betamethasone
    • Cortisone Acetate
    • Cyclosporine
    • Hydrocortisone
    • Methotrexate
    • Olopatadine Hydrochloride
    • Tacrolimus

  • Light Therapy
  • Biologics
    • Research and Development
    • Market Size and Growth

  • Global Market by Type
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World
      • Future of the Market
      • Competitive Analysis

Chapter Eleven: Prescription Skin Cancer Drugs

  • Overview
  • Nonmelanoma Skin Cancers
    • Actinic Keratoses
    • Basal Cell Carcinoma
    • Squamous Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dysplastic Nevus Syndrome

  • Malignant Melanoma
  • Description of Products
  • 5-Fluorouracil
  • Mechlorethamine/Nitrogen Mustard
  • Carmustine/BCNU (Topical)
  • Vinblastine (Intralesional) and Others
  • Research and Development
  • Market Size and Growth
  • Global Market
  • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World

  • The Future of the Market
  • Competitive Analysis

Chapter Twelve: Miscellaneous Skin Disorder Drugs—Antivirals and Antiparasitics

  • Overview
    • Antivirals
    • Antiparasitics

  • Description of Products
    • Topical Antivirals
    • Antiviral Drugs
    • Immunoenhancing Drugs
    • Current Suppliers
    • Antiparasitic Agents
    • Current Suppliers

  • Research and Development
  • Market Size and Growth
    • Global Market
    • Markets by Geographical Region
    • United States
    • Europe
    • Japan
    • Rest of World

  • The Future of the Market
  • Competitive Analysis

Chapter Thirteen: World Market Summary

  • Overview
  • Total Market Size and Forecast
  • Market and Competitive Analysis

Chapter Fourteen: Corporate Profiles

    • Allergan Inc.
    • Allergan Inamed Corporation
    • Barrier Therapeutics, Inc
    • Bayer AG
    • Bradley Pharmaceuticals, Inc
    • Bristol-Myers Squibb
    • CollaGenex Pharmaceuticals
    • Galderma S.A.
    • Genentech, Inc.
    • GlaxoSmithKline Plc
    • Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil)
    • Medicis Pharmaceutical Corporation
    • Merck & Company, Inc.
    • Mylan Pharmaceuticals, Inc,
    • Novartis Pharmaceuticals Corporation
    • Nycomed Inc.
    • Pfizer, Inc.
    • Q-Med AB
    • Roche Group (F. Hoffmann-La Roche Ltd.)
    • Schering-Plough Corporation
    • Sinclair Pharma Plc.
    • SkinMedica
    • Stiefel Laboratories, Inc.
    • Valeant Pharmaceuticals, Inc.

Appendix: Company Directory

List of Exhibits

Chapter One: Executive Summary

  • Table 1-1: The Global Market for Prescription Dermatological Drugs 2002, 2006, and 2011
  • Figure 1-1: The Global Market for Prescription Dermatological Drugs 2002, 2006, and 2011

Chapter Two: Introduction
  • Table 2-1: Common Bases for Topical Dermatological Medications
  • Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic Conditions

Chapter Three: Issues and Trends
  • Table 3-1: Selected Dermatological Rx-to-OTC Switches
  • Table 3-2: Selected Potential Prescription Dermatological Rx-to-OTC Switches

Chapter Four: Prescription Antiacne and Rosacea Drugs
  • Table 4-1: Common Benzoyl Peroxide Formulations
  • Table 4-2: Common Retinoid Formulations
  • Table 4-3: Common Antibiotic Formulations
  • Table 4-4: Common Oral Contraceptive Formulations
  • Table 4-5: Prescription Acne and Rosacea Formulations in Development
  • Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by Type 2002-2011
  • Figure 4-1: The Global Market for Prescription Acne and Rosacea Drugs Revenues by Type 2000-2010
  • Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2006
  • Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs Share by Type 2011
  • Table 4-8: The Global Market for Prescription Antiacne and Rosacea Drugs by Geographical Region 2000-2011
  • Figure 4-4: The Global Market for Prescription Antiacne and Rosacea Drugs Revenues by Geographical Region 2000-2011
  • Figure 4-5: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2006
  • Figure 4-6: The Global Market for Prescription Antiacne and Rosacea Drugs Share by Geographical Region 2011
  • Table 4-14: Global Market for Prescription Antiacne and Rosacea Drugs Revenues and Market Share by Supplier 2006
  • Figure 4-7: Global Market for Acne and Rosacea Drugs Market Share by Leading Supplier 2006

Chapter Five: Prescription Antiaging and Photodamage Drugs
  • Table 5-1: Common Prescription Keratolytic Formulations
  • Table 5-2: Occlusive Moisturizers—Categories of Ingredients
  • Table 5-3: Common Prescription Moisturizers
  • Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
  • Table 5-5: Common Prescription Sunscreens
  • Table 5-6: Other Prescription Antiaging and Photodamage Products
  • Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type 2000-2011
  • Figure 5-1: The Global Market for Antiaging and Photodamage Drugs Revenues by Type 2000-2011
  • Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share by Type 2006
  • Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share by Type 2011
  • Table 5-10: The Global Market for Prescription Antiaging and Photodamage Drugs by Geographical Region 2000-2006
  • Figure 5-4: The Global Market for Prescription Antiaging and Photodamage Drugs, Revenues by Geographical Region 2000-2011
  • Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2006
  • Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share by Geographical Region 2011
  • Table 5-16: Global Market for Prescription Antiaging and Photodamage Drugs Revenues and Market Share by Supplier 2006
  • Figure 5-7: Global Market for Prescription Antiaging and Photodamage Drugs, Market Share by Leading Supplier 2006

Chapter Six: Prescription Dermatitis and Seborrhea Drugs
  • Table 6-1: Common Prescription Topical Corticosteroid Preparations
  • Table 6-2: Common Prescription Systemic Corticosteroids
  • Table 6-3: Prescription Dermatitis Formulations in Development
  • Table 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Type 2000-2011
  • Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Type 2002-2011
  • Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2006
  • Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Type 2011
  • Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs by Geographical Region 2002-2011
  • Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues by Geographical Region 2002-2011
  • Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2006
  • Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea Drugs Share by Geographical Region 2011
  • Table 6-12: Global Market for Prescription Dermatitis and Seborrhea Drugs Revenues and Market Share by Supplier 2002
  • Figure 6-7: Global Market for Prescription Dermatitis and Seborrhea Drugs Market Share by Leading Supplier 2006

Chapter Seven: Prescription Antifungal Drugs
  • Table 7-1: Common Prescription Systemic Antifungal Dermatological Formulations
  • Table 7-2: Common Prescription Topical Antifungal Dermatological Drugs
  • Table 7-3: Prescription Antifungal Dermatological Drugs in Development
  • Table 7-4: The Global Market for Prescription Antifungal Dermatological Drugs by Type 2002-2011
  • Figure 7-1: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Type 2002-2011
  • Figure 7-2: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2006
  • Figure 7-3: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Type 2011
  • Table 7-6: The Global Market for Prescription Antifungal Dermatological Drugs by Geographical Region 2002-2006
  • Figure 7-4: The Global Market for Prescription Antifungal Dermatological Drugs Revenues by Geographical Region 2002-2006
  • Figure 7-5: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2006
  • Figure 7-6: The Global Market for Prescription Antifungal Dermatological Drugs, Share by Geographical Region 2011
  • Table 7-12: Global Market for Prescription Antifungal Dermatological Drugs Revenues and Market Share by Supplier 2006
  • Figure 7-7: Global Market for Prescription Antifungal Dermatological
  • Drugs Market Share by Leading Supplier 2006

Chapter Eight: Prescription Hair Loss and Hair Removal Drugs
  • Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
  • Table 8-2: Prescription Hair Loss or Hair Removal Formulations in Development
  • Table 8-3: The Global Market for Prescription Hair Loss and Hair Removal Drugs by Type 2002-2011
  • Figure 8-1: The Global Market for Prescription Hair Loss and Hair
  • Removal Drugs Revenues by Type 2002-2011
  • Figure 8-2: The Global Market for Prescription Hair Loss and Hair
  • Removal Drugs, Share by Type 2006
  • Figure 8-3: The Global Market for Prescription Hair Loss and Hair
  • Removal Drugs, Share by Type 2011
  • Table 8-5: The Global Market for Prescription Hair Loss and Hair
  • Removal Drugs Revenues by Geographical Region 2002-2011
  • Figure 8-4: The Global Market for Prescription Hair Loss and Hair
  • Removal Drugs Revenues by Geographical Region 2002-2011
  • Figure 8-5: The Global Market for Prescription Hair Loss and Hair
  • Removal Drugs Share by Geographical Region 2006
  • Figure 8-6: The Global Market for Prescription Hair Loss and Hair
  • Removal Drugs Share by Geographical Region 2011
  • Table 8-11: Global Market for Prescription Hair Loss and Hair Removal Drugs Revenues and Market Share by Supplier 2006
  • Figure 8-7: Global Market for Prescription Hair Loss and Hair Removal Drugs Market Share by Leading Supplier 2006

Chapter Nine: Prescription Hyperpigmentation/Melasma Drugs
  • Table 9-1: Common Prescription Hyperpigmentation/Melasma
  • Formulations
  • Table 9-2: Common Prescription Depigmenting Agents
  • Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type 2002-2012
  • Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs Revenues by Type 2002-2012
  • Figure 9-2: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Type 2006
  • Figure 9-3: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Share by Type 2011
  • Table 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs by Geographical Region 2002-2011
  • Figure 9-4: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs Revenues by Geographical Region 2002-2011
  • Figure 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2006
  • Figure 9-6: The Global Market for Prescription Hyperpigmentation/ Melasma Drugs, Share by Geographical Region 2011

Chapter Ten: Prescription Psoriasis Drugs
  • Table 10-1: Common Prescription Psoriasis Preparations
  • Table 10-2: Prescription Psoriasis Preparations in Development
  • Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type 2002-2011
  • Figure 10-1: The Global Market for Prescription Psoriasis Drugs Revenues by Type 2002-2011
  • Figure 10-2: The Global Market for Prescription Psoriasis Drugs Share by Type 2006
  • Figure 10-3: The Global Market for Prescription Psoriasis Drugs Share by Type 2011
  • Table 10-5: The Global Market for Prescription Psoriasis Drugs by Geographical Region 2002-2011
  • Figure 10-4: The Global Market for Prescription Psoriasis Drugs Revenues by Geographical Region 2002-2011
  • Figure 10-5: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2006
  • Figure 10-6: The Global Market for Prescription Psoriasis Drugs Share by Geographical Region 2011
  • Table 10-11: Global Market for Prescription Psoriasis Drugs Revenues and Market Share by Supplier 2006
  • Figure 10-7: Global Market for Prescription Psoriasis Drugs Market Share by Leading Supplier 2006

Chapter Eleven: Prescription Skin Cancer Drugs
  • Table 11-1: Malignant Conditions of the Skin
  • Table 11-2: Common Prescription Topical and Intralesional Chemotherapeutic Agents
  • Table 11-3: Prescription Skin Cancer Preparations in Development
  • Table 11-4: The Global Market for Skin Cancer Drugs 2002-2011
  • Figure 11-1: The Global Market for Skin Cancer Drugs 2002-2011
  • Table 11-5: The Global Market for Prescription Skin Cancer Drugs by Geographical Region 2002-2011
  • Figure 11-2: The Global Market for Prescription Skin Cancer Drugs Revenues by Geographical Region 2002-2011
  • Figure 11-3: The Global Market for Prescription Skin Cancer Drugs
  • Share by Geographical Region 2006
  • Figure 11-4: The Global Market for Prescription Skin Cancer Drugs Share by Geographical Region 2011
  • Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues and Market Share by Supplier 2006
  • Figure 11-9: Global Market for Skin Cancer Drugs Market Share by Leading Supplier 2006

Chapter Twelve: Miscellaneous Skin Disorder Drugs—Antivirals and Antiparasitics
  • Table 12-1: Common Prescription Topical Antiviral Formulations
  • Table 12-2: Common Prescription Topical Antiparasitic Formulations
  • Table 12-3: The Global Market for Prescription Miscellaneous Skin Disorder Drugs by Type 2002-2011
  • Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs Revenues by Type 2002-2006
  • Table 12-5: The Global Market for Prescription Miscellaneous Drugs by Geographical Region 2002-2011
  • Figure 12-2: The Global Market for Prescription Miscellaneous Drugs Revenues by Geographical Region 2002-2011
  • Figure 12-3: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2006
  • Figure 12-6: The Global Market for Prescription Miscellaneous Drugs Share by Geographical Region 2011

Chapter Thirteen: World Market Summary
  • Table 13-1: The Global Market for Prescription Dermatological Drugs, Revenues by Segment, 2000-2011
  • Figure 13-1: The Global Market for Prescription Dermatological Drugs Revenues by Dermatological Segment, 2002-2011
  • Figure 13-2: The Global Market for Dermatological Drugs Market Share by Type 2006
  • Figure 13-3: The Global Market for Prescription Dermatological Drugs Market Share by Type 2011
  • Table 13-3: Global Market for Prescription Dermatological Drugs Revenues and Segments of Participation by Leading Market Participants 2006

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report